Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA ALKEM LABORATORIES ALEMBIC PHARMA/
ALKEM LABORATORIES
 
P/E (TTM) x 41.7 32.8 127.0% View Chart
P/BV x 2.3 4.3 52.9% View Chart
Dividend Yield % 1.7 1.1 150.8%  

Financials

 ALEMBIC PHARMA   ALKEM LABORATORIES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-22
ALKEM LABORATORIES
Mar-22
ALEMBIC PHARMA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,0904,068 26.8%   
Low Rs6722,671 25.2%   
Sales per share (Unadj.) Rs269.9889.4 30.4%  
Earnings per share (Unadj.) Rs26.2140.5 18.7%  
Cash flow per share (Unadj.) Rs40.8166.0 24.6%  
Dividends per share (Unadj.) Rs10.0034.00 29.4%  
Avg Dividend yield %1.11.0 112.5%  
Book value per share (Unadj.) Rs266.5722.4 36.9%  
Shares outstanding (eoy) m196.56119.57 164.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.33.8 86.2%   
Avg P/E ratio x33.624.0 140.1%  
P/CF ratio (eoy) x21.620.3 106.3%  
Price / Book Value ratio x3.34.7 70.9%  
Dividend payout %38.124.2 157.6%   
Avg Mkt Cap Rs m173,172402,868 43.0%   
No. of employees `000NANA-   
Total wages/salary Rs m11,33019,627 57.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,058106,342 49.9%  
Other income Rs m5051,627 31.0%   
Total revenues Rs m53,563107,968 49.6%   
Gross profit Rs m8,74120,380 42.9%  
Depreciation Rs m2,8683,040 94.3%   
Interest Rs m177524 33.9%   
Profit before tax Rs m6,20118,443 33.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,0451,640 63.7%   
Profit after tax Rs m5,15716,803 30.7%  
Gross profit margin %16.519.2 86.0%  
Effective tax rate %16.88.9 189.5%   
Net profit margin %9.715.8 61.5%  
BALANCE SHEET DATA
Current assets Rs m29,74884,354 35.3%   
Current liabilities Rs m18,30648,053 38.1%   
Net working cap to sales %21.634.1 63.2%  
Current ratio x1.61.8 92.6%  
Inventory Days Days1142 25.1%  
Debtors Days Days665 8.6%  
Net fixed assets Rs m42,55443,245 98.4%   
Share capital Rs m393239 164.4%   
"Free" reserves Rs m51,98286,134 60.4%   
Net worth Rs m52,37586,373 60.6%   
Long term debt Rs m094 0.0%   
Total assets Rs m72,302127,599 56.7%  
Interest coverage x36.036.2 99.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.70.8 88.1%   
Return on assets %7.413.6 54.3%  
Return on equity %9.819.5 50.6%  
Return on capital %12.221.9 55.5%  
Exports to sales %43.818.7 233.9%   
Imports to sales %12.70-   
Exports (fob) Rs m23,25119,924 116.7%   
Imports (cif) Rs m6,728NA-   
Fx inflow Rs m23,25119,924 116.7%   
Fx outflow Rs m6,7283,911 172.0%   
Net fx Rs m16,52316,013 103.2%   
CASH FLOW
From Operations Rs m5,52411,110 49.7%  
From Investments Rs m-3,720-14,351 25.9%  
From Financial Activity Rs m-2,1743,796 -57.3%  
Net Cashflow Rs m-370580 -63.8%  

Share Holding

Indian Promoters % 69.1 57.2 120.9%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 17.9 20.2 88.5%  
FIIs % 5.3 4.5 119.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 42.8 70.9%  
Shareholders   103,811 79,721 130.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on ALEMBIC PHARMA vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs ALKEM LABORATORIES Share Price Performance

Period ALEMBIC PHARMA ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day 0.49% 0.34% 0.23%
1-Month 9.17% -1.10% 0.36%
1-Year -25.08% -12.29% -6.87%
3-Year CAGR 1.98% 14.98% 20.16%
5-Year CAGR 3.24% 9.37% 11.07%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of ALKEM LABORATORIES the stake stands at 57.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 38.1%.

ALKEM LABORATORIES paid Rs 34.0, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Mark Mobius on Cryptos | Dharmaj Crop IPO Fully Subscribed on Debut | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets hit new records following heavy gains from Reliance and other oil marketing companies as crude prices fell.